1. MD-PhD Program
Image of Scientist

Mount Sinai Academy of Physician-Scientists

Physician-Scientists at Mount Sinai

The Mount Sinai Academy of Physician-Scientists (MAPS) brings together physician-scientists across the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System, from students and residents to fellows and faculty. The Academy fosters a dynamic and collaborative community committed to advancing discovery, mentorship, and innovation in translational medicine. Through shared programming and cross-disciplinary engagement, MAPS strengthens the pipeline of physician-scientist development and amplifies Mount Sinai’s leadership in biomedical research.  

Physician-Scientists at Mount Sinai

Planning Committee

Alexander Charney, MD, PhD
Alexander Charney, MD, PhD

Associate Professor, Artificial Intelligence and Human Health, Psychiatry, Genetics and Genomic Sciences, Neurosurgery, Neuroscience

Jaime Chu, MD
Jaime Chu, MD

Associate Director of the MD/PhD (MSTP) Program at the Mount Sinai Kravis Children’s Hospital; Associate Chief, Division of Pediatric Hepatology;  
Professor, Pediatrics, Hepatology 

Miriam Merad, MD, PhD
Miriam Merad, MD, PhD

Chair, Immunology & Immunotherapy; Director, Precision Immunology Institute; Professor, Immunology & Immunotherapy, Oncological Sciences, Medicine, Hematology and Medical Oncology, Dermatology

Talia H Swartz, MD, PhD
Talia H Swartz, MD, PhD

Director, MD-PhD Program; Associate Professor, Medicine, Infectious Diseases, Medical Education

Our Physician-Scientist Achievements

Fanny Elahi headshot

Redefining Alzheimer's Diagnosis

Fanny Elahi, MD, PhD leads Mount Sinai's pioneering use of blood-based biomarkers for early Alzheimer's detection, enabling noninvasive diagnosis and earlier intervention.

Alexander Charney

Dr. Charney Challenges Postmortem Brain Research

Research from Alexander Charney, MD, PhD, revealed significant differences in RNA splicing and protein expression between living and postmortem brain tissue.

Jean-Frederic Colombel

The Preclinical Phase of IBD Revealed

Jean-Frederic Colombel, MD, identifies immune pathway changes years before Crohn's disease symptoms appear, opening new possibilities for disease prediction and prevention through biomarker analysis.